Pooja Khandelwal, MD

Assistant Professor, UC Department of Pediatrics

Phone 513-803-9063

Email pooja.khandelwal@cchmc.org

Clinical

Pediatric bone marrow transplantation; acute graft versus host disease

Research

Acute graft versus host disease biology; treatment of steroid refractory acute graft versus host disease; management of refractory autoimmune cytopenias in the post-transplant setting

MD: Kasturba Medical College, Manipal, India, 2005.

Residency: University of Arizona College of Medicine, Tucson, AZ, 2010.

Fellowship: Cincinnati Children's Hospital Medical Center, 2013.

View PubMed Publications

Khandelwal P, Marsh RA, Davies SM, Jodele S, Grimley MS, Jordan MB, Filipovich AJ.Bortezomib for refractory autoimmunity in pediatrics. Biol Blood Marrow Transplant. 2014 Oct;20(10):1654-9.

Khandelwal P, Marsh R, Schmid DS, Folster J, Radford KW, Davies SM, Filipovich A. Non dermatomal rash and pancytopenia in a 5 year old child. J Clin Virol. 2014 Jun;60(2):81-3.

Khandelwal P, Brewer AJ, Minevich E, Miles L, Geller JI. High-grade transitional cell carcinoma of the bladder in a 5 year old successfully treated with partial cystectomy and intravesical Bacillus Calmette-Guerin. Journal of Pediatric Hematology/Oncology. 2014 May;36(4):e234-6.

Khandelwal P, Lawrence J ,  Filipovich AH ,  Davies SM, Bleesing, Jordan  MB, Mehta PA ,Jodele S,  Grimley MS,  Kumar A,  Myers K, Marsh RA. The successful use of Alemtuzumab for treatment of steroid refractory acute graft versus host disease in pediatric patients. Pediatr Transplant. 2014 Feb;18(1):94-102.

Bhatt SP, Khandelwal P, Nanda S, Stoltzfus JC, Fioravanti GT. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respir Med. 2008 Jul;102:999-1003.